【结 构 式】 |
【分子编号】41585 【品名】 【CA登记号】 |
【 分 子 式 】C15H10Cl2N4O2 【 分 子 量 】349.17556 【元素组成】C 51.6% H 2.89% Cl 20.31% N 16.05% O 9.16% |
合成路线1
该中间体在本合成路线中的序号:(V)
【1】 Yang N, DOng JJ, Liu KI,et a1.2005.Synthe^18 0f bosentan as an end.thelin receptor antngonisL中国药物化学杂志,15 (4): 230~233 |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 13182 | Guaiacol; 2-Methoxyphenol | 90-05-1 | C7H8O2 | 详情 | 详情 |
(II) | 61569 | dimethyl 2-(2-methoxyphenoxy)malonate | C12H14O6 | 详情 | 详情 | |
(III) | 66160 | pyrimidine-2-carboximidamide hydrochloride | C5H7ClBN4 | 详情 | 详情 | |
(IV) | 50370 | 5-(2-methoxyphenoxy)-2-(2-pyrimidinyl)-4,6(1H,5H)-pyrimidinedione | C15H12N4O4 | 详情 | 详情 | |
(V) | 41585 | C15H10Cl2N4O2 | 详情 | 详情 | ||
(VI) | 50371 | 4-(tert-Butyl)benzenesulphonamide | C10H15NO2S | 详情 | 详情 | |
(VII) | 50372 | C25H24ClN5O4S | 详情 | 详情 | ||
(VIII) | 50374 | C31H37N5O6S | 详情 | 详情 | ||
(IX) | 50375 | C28H29N5O7S | 详情 | 详情 |
合成路线2
该中间体在本合成路线中的序号:(IV)The condensation of diethyl (2-methoxyphenoxy)malonate (I) with pyrimidine-2-carboxamidine (II) by means of NaOMe (Na in MeOH), followed by treatment with NaOH, provides the dihydroxy pyrimidine derivative (III), which is converted into the dichloro derivative (IV) by treatment with refluxing PCl5 and DIEA. Compound (IV) can also be obtained from the pyrimidinedione (V) by reaction with phosphorus oxychloride at 90 C. Reaction of compound (IV) with 4-tert-butylbenzenesulfonamide (VI), performed either directly in DMSO or by means of benzyltriethylammonium chloride (BTEAC) or tetrabutylammonium bromide (TBAB) and K2CO3 in refluxing toluene, gives compound (VII). Finally, this compound is converted into bosentan by reaction with sodium and ethylene glycol (VIII).
【1】 Mealy, N.E.; del Fresno, M.; Bayes, M.; Bosentan. Drugs Fut 2001, 26, 12, 1149. |
【2】 Burri, K.; Clozel, M.; Fischli, W.; Hirth, G.; Loffler, B.-M.; Ramuz, H.; Neidhart, W. (F. Hoffmann-La Roche AG); Sulfonamide, preparation and use thereof as medicine and intermediate. EP 0526708; JP 1993222003; US 4292740 . |
【3】 Dehoff, B.S.; Harrington, P.J.; Khatri, H.N. (Roche Colorado Corp.); Preparation of sulfonamides. US 6136971 . |
【4】 Harrington, P.J.; Dehoff, B.S.; Khatri, H.N. (F. Hoffmann-La Roche AG); Preparation of sulfonamides. WO 0155120 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 50138 | diethyl 2-(2-methoxyphenoxy)malonate | C14H18O6 | 详情 | 详情 | |
(II) | 50368 | 2-pyrimidinecarboximidamide | C5H6N4 | 详情 | 详情 | |
(III) | 50369 | C15H12N4O4 | 详情 | 详情 | ||
(IV) | 41585 | C15H10Cl2N4O2 | 详情 | 详情 | ||
(V) | 50370 | 5-(2-methoxyphenoxy)-2-(2-pyrimidinyl)-4,6(1H,5H)-pyrimidinedione | C15H12N4O4 | 详情 | 详情 | |
(VI) | 50371 | 4-(tert-Butyl)benzenesulphonamide | C10H15NO2S | 详情 | 详情 | |
(VII) | 50372 | C25H24ClN5O4S | 详情 | 详情 | ||
(VIII) | 11295 | Polyethylene glycol;1,2-Ethanediol;Monoethylene glycol; Ethylene glycol | 107-21-1 | C2H6O2 | 详情 | 详情 |
(IX) | 50373 | 2-tert-Butoxyethanol; Ethylene glycol mono-tert-butyl ester | 7580-85-0 | C6H14O2 | 详情 | 详情 |
(X) | 50374 | C31H37N5O6S | 详情 | 详情 | ||
(XI) | 50375 | C28H29N5O7S | 详情 | 详情 |
合成路线3
该中间体在本合成路线中的序号:(VIII)The conversion of 2-chloropyrimidine (I) to pyrimidine-2-carboxamidine (III) is performed by known methods through the intermediate pyrimidine-2-carbonitrile (II). The cyclization of (III) with 2-(2-methoxyphenoxy)malonic acid diethyl ester (IV) -prepared by condensation of 2-chloromalonic acid diethyl ester (V) with guaiacol (VI)- yields the bipyrimidinedione (VII). This compound is treated with refluxing POCl3 to afford the dichlorobipyrimidine (VIII). The chlorine monosubstitution in (VIII) with 4-tert-butylphenylsulfonamide (IX), K2CO3 and tetrabutylammonium bromide (TBAB) in toluene provides the substituted sulfonamide (X), which is submitted to a second chlorine substitution with ethyleneglycol mono-tert-butyl ether (XI) by means of NaOH in hot toluene to give the tert-butyl-intermediate (XII). Finally, this compound is deprotected by reaction with formic acid yielding the formate ester (XIII), which is hydrolyzed with NaOH in ethanol/water, and submitted to crystallization in refluxing ethanol/water to afford the target bosentan.
【1】 Harrington, P.J.; Khatri, H.N.; DeHoff, B.S.; Guinn, M.R.; Boehler, M.A.; Glaser, K.A.; Research and development of a second-generation process for bosentan, and endothelin receptor antagonist. Org. Proc. Res. & Develop. 2002, 6, 2, 120. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 11191 | 2-Chloropyrimidine | 1722-12-9 | C4H3ClN2 | 详情 | 详情 |
(II) | 61568 | 2-Pyrimidinecarbonitrile; 2-Cyanopyrimidine | 14080-23-0 | C5H3N3 | 详情 | 详情 |
(III) | 50368 | 2-pyrimidinecarboximidamide | C5H6N4 | 详情 | 详情 | |
(IV) | 61569 | dimethyl 2-(2-methoxyphenoxy)malonate | C12H14O6 | 详情 | 详情 | |
(V) | 59503 | dimethyl chloromalonate | 28868-76-0 | C5H7ClO4 | 详情 | 详情 |
(VI) | 13182 | Guaiacol; 2-Methoxyphenol | 90-05-1 | C7H8O2 | 详情 | 详情 |
(VII) | 50370 | 5-(2-methoxyphenoxy)-2-(2-pyrimidinyl)-4,6(1H,5H)-pyrimidinedione | C15H12N4O4 | 详情 | 详情 | |
(VIII) | 41585 | C15H10Cl2N4O2 | 详情 | 详情 | ||
(IX) | 50371 | 4-(tert-Butyl)benzenesulphonamide | C10H15NO2S | 详情 | 详情 | |
(X) | 50372 | C25H24ClN5O4S | 详情 | 详情 | ||
(XI) | 50373 | 2-tert-Butoxyethanol; Ethylene glycol mono-tert-butyl ester | 7580-85-0 | C6H14O2 | 详情 | 详情 |
(XII) | 50374 | C31H37N5O6S | 详情 | 详情 | ||
(XIII) | 50375 | C28H29N5O7S | 详情 | 详情 |
合成路线4
该中间体在本合成路线中的序号:(I)The known dichloropyrimidine derivative (I) was condensed with 2-phenylethenesulfonamide (II) in the presence of NaH in DMF to furnish the N-pyrimidinylsulfonamide (III). Displacement of the remaining chlorine of (III) by means of methanolic NaOMe provided the corresponding methyl ether (IV). The title potassium salt was then prepared by treatment of sulfonamide (IV) with ethanolic KOH.
【1】 Harada, H.; Kazami, J.; Watanuki, S.; Tsuzuki, R.; Sudou, K.; Tanaka, A. (Yamanouchi Pharmaceutical Co., Ltd.); Arylethenesulfonamide derivs. and drug compsn. containing the same. EP 0882719; US 6083955; WO 9722595 . |
合成路线5
该中间体在本合成路线中的序号:(I)Nucleophilic substitution of the dichloropyrimidine derivative (I) with 2-phenylvinylsulfonamide (II) in the presence of NaH in DMF affords the sulfonamido pyrimidine (III). The remaining chloro group of (III) is subsequently displaced with the sodium alkoxide derived from 2-fluoroethanol (IV) to provide the target fluoroethyl ether.
【1】 Harada, H.; Kazami, J.-I:; Watanuki, S.; Tsuzuki, R.; Yanagisawa, I.; Sudoh, K.; Tsukamoto, S.-I.; Tanaka, A.; Fujimori, A.; Ethenesulfonamide derivatives, a novel class of orally active endothelin-A receptor antagonists. Chem Pharm Bull 2001, 49, 5, 606. |
【2】 Harada, H.; Kazami, J.; Watanuki, S.; Tsuzuki, R.; Sudou, K.; Tanaka, A. (Yamanouchi Pharmaceutical Co., Ltd.); Arylethenesulfonamide derivs. and drug compsn. containing the same. EP 0882719; US 6083955; WO 9722595 . |
合成路线6
该中间体在本合成路线中的序号:(IV)The sulfonation of 1-phenyl-1-butene (I) with sulfuryl chloride in hot DMF provided sulfonyl chloride (II), which was then treated with ammonium hydroxyde to give sulfonamide (III). Coupling of the known dichloro bipyrimidinyl derivative (IV) with the sodium salt of sulfonamide (III) yielded the N-pyrimidinyl sulfonamide (V). The remaining chloride was then displaced with sodium methoxide in DMF, and the resultant sulfonamide was finally converted to the potassium salt with ethanolic KOH.
【1】 Harada, H.; Kazami, J.-I.; Watanuki, S.; Tsuzuki, R.; Sudoh, K.; Fujimori, A.; Tokunaga, T.; Tanaka, A.; Tsukamoto, S.-I.; Yanagisawa, I.; Synthesis and structure-activity relationships in a series of ethenesulfonamide derivatives, a novel class of endothelin receptor antagonists. Chem Pharm Bull 2001, 49, 12, 1593. |
【2】 Harada, H.; Kazami, J.; Watanuki, S.; Tsuzuki, R.; Sudou, K.; Tanaka, A. (Yamanouchi Pharmaceutical Co., Ltd.); Arylethenesulfonamide derivs. and drug compsn. containing the same. EP 0882719; US 6083955; WO 9722595 . |